Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Domino Printing Sciences develops and manufactures coding, marking, and digital printing technologies used globally across multiple industries including pharmaceuticals, life sciences, food, beverage, and packaging. While it supplies critical hardware/software platforms such as the K600G printer for dose-level serialization required by pharma regulations, it does not research or manufacture drugs or medical devices itself. The company was acquired by Japan’s Brother Industries in 2015 but continues to operate under its own brand name from its UK headquarters. Domino employs about 3,000 people worldwide and has an annual revenue approaching $909 million USD.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Domino Printing Sciences.